Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
7.25
+1.10 (17.89%)
At close: Nov 13, 2026, 4:00 PM EST
7.39
+0.14 (1.93%)
After-hours: Nov 13, 2026, 6:50 PM EST
Orchestra BioMed Holdings Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Orchestra BioMed Holdings stock has a consensus rating of "Strong Buy" and an average price target of $12.33. The average 1-year stock price forecast is 70.07% higher than the current stock price, while the lowest is $9.00 (+24.14%) and the highest is $20 (+175.86%).
Price Target: $12.33 (+70.07%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Orchestra BioMed Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +65.52% | Nov 13, 2026 |
| BTIG | BTIG | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +65.52% | Nov 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +65.52% | Oct 15, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $11 | Buy | Reiterates | $11 | +51.72% | Oct 2, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $15 | Buy | Reiterates | $15 | +106.90% | Sep 25, 2026 |
Financial Forecast
Revenue This Year
451.14K
from 33.48M
Decreased by -98.65%
Revenue Next Year
633.50K
from 451.14K
Increased by 40.42%
EPS This Year
-1.52
from -1.11
EPS Next Year
-1.54
from -1.52
EPS and Forward PE are based on non-GAAP adjusted numbers.